These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 34264887)
21. Colchicine for the prevention of ischemic stroke: An updated meta-analysis of randomized clinical trials. Al-Atta A; Kuzemczak M; Alkhalil M Brain Circ; 2021; 7(3):187-193. PubMed ID: 34667902 [TBL] [Abstract][Full Text] [Related]
22. Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis. Aimo A; Pascual Figal DA; Bayes-Genis A; Emdin M; Georgiopoulos G Eur J Clin Invest; 2021 Apr; 51(4):e13464. PubMed ID: 33251579 [TBL] [Abstract][Full Text] [Related]
23. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials. Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166 [TBL] [Abstract][Full Text] [Related]
25. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study. Huang H; Yu Y; Chen L; Chen S; Tang R; Li Q; Wei W; Bao K; Huang Z; Lai W; Wang B; Tan N; Chen J; Liu J; Liu Y BMC Cardiovasc Disord; 2021 Dec; 21(1):613. PubMed ID: 34961476 [TBL] [Abstract][Full Text] [Related]
26. Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials. Xu H; Mao L; Liu H; Lin Z; Zhang Y; Yang J Heart Lung Circ; 2022 May; 31(5):685-695. PubMed ID: 35033433 [TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis. Wang H; Jiang M; Li X; Zhao Y; Shao J; Liu Z; Lin L; Xu Q; Wang L; Lu X; Zhang H; Chen Y; Zhang R Front Cardiovasc Med; 2021; 8():726341. PubMed ID: 34513960 [No Abstract] [Full Text] [Related]
29. Colchicine efficacy and safety for the treatment of cardiovascular diseases. Andreis A; Imazio M; Casula M; Avondo S; De Ferrari GM Intern Emerg Med; 2021 Sep; 16(6):1691-1700. PubMed ID: 33704674 [TBL] [Abstract][Full Text] [Related]
30. Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis. Shrestha DB; Budhathoki P; Sedhai Y; Khadka M; Pokharel S; Yadav S; Patel T; Elgendy I; Mir WAY; Patel NK J Cardiovasc Pharmacol; 2022 Apr; 79(4):420-430. PubMed ID: 34935703 [TBL] [Abstract][Full Text] [Related]
31. Clinical and prognostic implications of C-reactive protein levels in myocardial infarction with nonobstructive coronary arteries. Eggers KM; Baron T; Hjort M; Nordenskjöld AM; Tornvall P; Lindahl B Clin Cardiol; 2021 Jul; 44(7):1019-1027. PubMed ID: 34032303 [TBL] [Abstract][Full Text] [Related]
32. Colchicine in Cardiovascular Disease: In-Depth Review. Deftereos SG; Beerkens FJ; Shah B; Giannopoulos G; Vrachatis DA; Giotaki SG; Siasos G; Nicolas J; Arnott C; Patel S; Parsons M; Tardif JC; Kovacic JC; Dangas GD Circulation; 2022 Jan; 145(1):61-78. PubMed ID: 34965168 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Different Dosing Regimens of Colchicine in Patients With Coronary Artery Disease: A Network Meta-analysis of 15 Randomized Controlled Trials. Wang S; Mu Y; Tan L; Hao J J Cardiovasc Pharmacol; 2023 Jul; 82(1):13-22. PubMed ID: 37026756 [TBL] [Abstract][Full Text] [Related]
34. Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials. Ma Z; Chen J; Jin K; Chen X Front Cardiovasc Med; 2022; 9():947959. PubMed ID: 36176989 [TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy. Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222 [TBL] [Abstract][Full Text] [Related]
37. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease. Nidorf M; Thompson PL Am J Cardiol; 2007 Mar; 99(6):805-7. PubMed ID: 17350370 [TBL] [Abstract][Full Text] [Related]